The Artificial Intelligence (AI) and Machine Learning industry is growing at an extraordinary rate, with healthcare professionals increasingly turning to AI to transform the patient experience and quality of care. 23 April 2020
Digital marketing in pharma is gaining increasing importance in recent times and Indian drugmaker can be termed as a pioneer in this space from the Indian market perspective, as it has successfully used a digital strategy to promote disease awareness and grow leadership position in asthma, says data and analytics company GlobalData. 4 March 2020
Researchers at the Massachusetts Institute of Technology (MIT) have claimed that they have identified a powerful new antibiotic compound using artificial intelligence (AI). 21 February 2020
finnCap, an adviser and broker to ambitious growth companies, has released a new report showing the extent to which healthcare companies can benefit from employing artificial intelligence (AI). 31 January 2020
A new report has been published by the joint Big Data Task Force of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). 20 January 2020
Novadiscovery, a French pioneer in the use of in silico clinical trials to predict drug efficacy and optimize clinical development, has raised five million euros ($6 million) in a Series A financing. 9 January 2020
In recent years, digital transformation has gone from being a promise to a reality, writes Francesca Domenech Wuttke, Chief Digital Officer, Almirall. 2 December 2019
Given that they have a certain luxury for blue sky thinking and the capacity to lead rather than react to industry and societal trends, for big pharma companies to have highly ambitious digital strategies is not unusual. 28 November 2019
Swedish drug developer Orexo today announced it has acquired the exclusive US rights to vorvida, a digital therapy for the treatment of alcohol use disorder (AUD), from GAIA AG, a global leader in digital therapeutics. 27 November 2019
Anglo-Swedish pharma major AstraZeneca’s love affair with China shows no sign of cooling off, with the company now announcing three new projects in the Asian country to advance its R&D efforts. 6 November 2019
Google and other search engines are putting consumers at risk of buying fake pharmaceutical products by refusing to remove these websites in their search results. 22 October 2019
China is currently the second largest pharmaceutical market in the world and is aiming to be a major innovator as well, as part of its ‘Made in China 2025’ program. 14 October 2019
Hong Kong-based Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical (CTFH), taking on previously undruggable targets. 9 October 2019
A new research collaboration between Danish diabetes giant Novo Nordisk and the Cambridge, USA-based firm bluebird bio will see the companies work together on certain in vivo gene editing technologies. 9 October 2019
Swiss pharma giant Novartis has launched a new digital collaboration with Microsoft, a software company, aimed at boosting the firm’s artificial intelligence capabilities. 1 October 2019
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 January 2025
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
The pharmacovigilance (PV) teams within the pharmaceutical industry currently report allocating 40 to 85% of budgets towards case processing. With case processing volumes growing at a rate of 10 to 15% annually, life sciences organizations are aiming to reduce costs and automate time-consuming processes while maintaining or improving quality. 9 December 2024
Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has entered a research collaboration and option agreement with US pharma major Bristol Myers Squibb. 4 December 2024
AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now raised more than $100 million in total, calls itself the leading platform for AI-powered protein engineering. 27 November 2024
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024